Sulfogaiacol + Pentoxyverine Citrate + Promethazine Hydrochloride Granules

Sulfogaiacol + Pentoxyverine Citrate + Promethazine Hydrochloride Granules is a fixed-dose combination product developed and marketed by Anhui Jiuhua Huayuan Pharmaceutical for the symptomatic treatment of cough and upper respiratory tract symptoms. The formulation combines three active small molecules: sulfogaiacol, which acts as an expectorant to increase respiratory tract secretions and facilitate mucus clearance; pentoxyverine citrate, a non-opioid antitussive that suppresses the cough reflex through sigma-1 receptor agonism and muscarinic antagonism; and promethazine hydrochloride, a first-generation H1-antihistamine that reduces allergic symptoms and provides mild sedation. This synergistic combination is administered orally in granule form and is approved in China for typical symptomatic relief in respiratory conditions.

Other names

Sulfogaiacol + Pentoxyverine Citrate + Promethazine HydrochlorideSulfogaiacol Pentoxyverine Citrate and Promethazine Hydrochloride Granules